Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

EHC vs UHS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EHC Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 8–2 Matrix Metrics)

EHC Overall Winner 6-Pillar Tally: EHC 4 – 2 UHS Matrix Metrics: EHC 8 – 2 UHS

As of Nov 20, 2026, Encompass Health Corporation (EHC) is the stronger overall head-to-head candidate over Universal Health Services, Inc. Class B (UHS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas UHS carries 45.6/100 (HOLD) at $179.43 (7.8x Forward P/E, 10.8% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About EHC vs UHS
EHC NYSE Head-to-Head Winner
Encompass Health Corporation Common Stock
Services-Hospitals
$133.65
+1.04% 1D
Market Cap $13.0B
TTM Revenue $6.34B
Forward P/E 19.4x
Beta / 30D Vol -0.10β · 40% Vol
Unified Composite Score
52.0 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 50
RSI-14: 49.8 · SMA20: $135.78 · SMA50: $128.15
UHS NYSE
Universal Health Services, Inc. Class B
Services-General Medical & Surgical Hospitals, Nec
$179.43
+2.54% 1D
Market Cap $10.1B
TTM Revenue $18.4B
Forward P/E 7.8x
Beta / 30D Vol 0.09β · 54% Vol
Unified Composite Score
45.6 / 100 HOLD
Tech 28.0 Fund 41.0 Flow 52.0 Mom 46.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 44
RSI-14: 43.7 · SMA20: $187.19 · SMA50: $182.50

6-Pillar Scorecard Institutional Category Breakdown (EHC 4 – 2 UHS)

Columns: Metric · EHC · UHS
1. Valuation Multiples UHS
Forward P/E 19.4x 7.8x
Trailing P/E 21.2x 7.3x
PEG Ratio 0.41x 1.41x
EV / Revenue 2.5x 0.9x
2. Growth & Scale EHC
Revenue Growth (YoY) +8.9% +5.3%
Earnings Growth (YoY) +21.6% -10.9%
TTM Revenue (USD) $6.34B $18.4B
Market Cap $13.0B $10.1B
3. Profitability & Quality EHC
Gross Margin 44.1% 44.5%
Operating Margin 18.4% 10.8%
Net Profit Margin 10.2% 8.0%
Return on Equity (ROE) 25.1% 19.7%
4. Balance Sheet & Cash Flow EHC
Cash Generation (TTM) $457M $1.09B
Cash Flow Margin 7.2% 6.0%
Net Cash / Leverage $2.73B Net Debt (1.05x D/E) $6.01B Net Debt (0.81x D/E)
Dividend Yield 0.58% 0.43%
5. Options & Positioning EHC
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 27.0% (8th %ile) 83.7% (22nd %ile)
Put/Call OI Skew 0.25x (Call-Skewed) 0.52x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat UHS
OpEx & R&D Intensity 25.7% of Rev ($1.63B) 33.7% of Rev ($6.18B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Medical Care Facilities Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: EHC (8) vs UHS (2)
Institutional Metric EHC UHS Criterion Row Edge
Market Capitalization
Scale
$13.0B $10.1B Larger Scale EHC
Trailing P/E Ratio
Valuation
21.2x 7.3x Lower Multiple UHS
Forward P/E Ratio
Valuation
19.4x 7.8x Lower Multiple UHS
Revenue Growth (YoY)
Growth
+8.9% +5.3% Higher Growth EHC
Operating Margin (TTM)
Profitability
18.4% 10.8% Higher Margin EHC
Net Profit Margin
Profitability
10.2% 8.0% Higher Margin EHC
Return on Equity (ROE)
Capital Efficiency
25.1% 19.7% Higher ROE EHC
52-Week Range Position
Momentum
80% ($93–$144) 37% ($140–$246) Stronger Trend EHC
Beta / 30D Volatility
Risk Regime
-0.10β · 40% Vol 0.09β · 54% Vol Lower Realized Risk EHC
Unified Institutional Score
Composite Signal
52.0 / 100 (HOLD) 45.6 / 100 (HOLD) Higher Composite EHC
Trailing 12M Revenue (USD)
Operating Scale
$6.34B $18.4B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
44.1% 44.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.41x PEG · 2.5x EV/Rev 1.41x PEG · 0.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$457M ($2.73B Net Debt (1.05x D/E)) $1.09B ($6.01B Net Debt (0.81x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EHC +10.68 pp
EHC: +6.06% · UHS: -4.62%
3M Horizon EHC +8.81 pp
EHC: +10.53% · UHS: +1.72%
6M Horizon EHC +13.62 pp
EHC: +27.33% · UHS: +13.71%
1Y Horizon EHC +40.7 pp
EHC: +19.42% · UHS: -21.28%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period EHC Revenue UHS Revenue EHC Op. Margin UHS Op. Margin Margin Leader
FY2018 $4.28B $10.8B 13.0% 10.9% EHC
FY2019 $4.61B $11.4B 13.3% 10.7% EHC
FY2020 $3.57B $11.6B 15.8% 11.8% EHC
FY2021 $4.01B $12.6B 13.9% 10.8% EHC
FY2022 $4.35B $13.4B 12.4% 7.5% EHC
FY2023 $4.80B $14.3B 7.3% 8.2% UHS
FY2024 $5.37B $15.8B 8.5% 10.6% UHS
FY2025 $5.94B $17.4B 9.5% 11.5% UHS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
EHC CONSOLIDATION
73d in phase · OBV DISTRIBUTION
Current IV 27.0%
IV Percentile 8th %ile
Put/Call OI Skew 0.25x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact EHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
UHS CONSOLIDATION
61d in phase · OBV NEUTRAL
Current IV 83.7%
IV Percentile 22nd %ile
Put/Call OI Skew 0.52x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact UHS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $197.80 · IV 31.2%

UHS Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($19,780)

Compare $19,780 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 31.2% ATM IV.

5-DAY BULLISH SWING Liq C

Dec 18 $200 / $210 Bull Call Spread

Buy 1x $200C · Sell 1x $210C · 31d

Net Entry $315 Debit
T+5d @ +5% Move +$199 (+63%)
Max Risk / Buffer $315 Capped
5d Edge & Liquidity 1.0x R:R · Liq C
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Dec 18 $185 / $165 Bull Put Spread

Sell 1x $185P · Buy 1x $165P · 31d

Net Entry $200 Credit
Max Credit / Yield +$200 (+11.1% RoM)
Max Risk / Buffer -7.5% Cushion ($1,800 Mgn)
5d Edge & Liquidity 78% PoP · Liq C
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq C

Dec 18 $185P / $200-$210C Seagull

Sell 1x $185P · Buy 1x $200/$210C · 31d

Net Entry $60 Debit
T+5d @ +5% Move +$385 (+12.9% RoM)
Max Risk / Buffer -6.5% Put Cushion ($2,991 Mgn)
5d Edge & Liquidity 0.7x R:R · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
EHC Moat Profile Scale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $13.0B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment 25.7% of Rev ($1.63B)
90D Engineering Disclosures 0 Published
UHS Moat Profile Scale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $10.1B market capitalization and 10.8% operating margin.
OpEx & R&D Reinvestment 33.7% of Rev ($6.18B)
90D Engineering Disclosures 0 Published

Investor FAQ EHC vs UHS Key Questions & Quantitative Answers

As of Nov 20, 2026, Encompass Health Corporation (EHC) is the stronger overall head-to-head candidate over Universal Health Services, Inc. Class B (UHS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas UHS carries 45.6/100 (HOLD) at $179.43 (7.8x Forward P/E, 10.8% operating margin). Technically, EHC sits in a Neutral phase (RSI 49.8, CONSOLIDATION options structure) and UHS sits in a Neutral phase (RSI 43.7, CONSOLIDATION options structure).

EHC leads the Growth & Scale pillar: EHC posts +8.9% YoY revenue growth and +21.6% YoY earnings growth on $6.34B TTM revenue (44.1% gross margin, 18.4% operating margin), compared with UHS at +5.3% YoY revenue growth and -10.9% YoY earnings growth on $18.4B TTM revenue (44.5% gross margin, 10.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), EHC cumulative revenue shifted +38.8% while UHS shifted +61.2%. In operating R&D and SG&A reinvestment, EHC deploys 25.7% of Rev ($1.63B) (0 90-day corporate R&D disclosures) versus 33.7% of Rev ($6.18B) (0 disclosures) for UHS.

UHS screens cheaper on headline valuation multiples. EHC trades at 19.4x Forward P/E, 21.2x Trailing P/E, 0.41x PEG, and 2.5x EV/Revenue (7.2% FCF margin), whereas UHS trades at 7.8x Forward P/E, 7.3x Trailing P/E, 1.41x PEG, and 0.9x EV/Revenue (6.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EHC (25.1% ROE) versus UHS (19.7% ROE) capital efficiency.

In options market volatility and institutional positioning, EHC carries 27.0% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.10β · 40% Vol realized risk). By comparison, UHS carries 83.7% implied volatility (22nd %ile, Compressed (<25th %ile)), a 0.52x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.09β · 54% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.